1. Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study
Burst et al. Am J Nephrol 2017;45:
(DOI: / )
Table 1. Baseline demographics and clinical characteristics

2. Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study
Burst et al. Am J Nephrol 2017;45:
(DOI: / )
Table 2. Baseline biochemical parameters

3. Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study
Burst et al. Am J Nephrol 2017;45:
(DOI: / )
Fig. 1. Differential diagnosis of SAIDH vs. TIH. ORs and 95% CIs for clinical and biochemical parameters calculated by univariate logistic regression.

4. Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study
Burst et al. Am J Nephrol 2017;45:
(DOI: / )
Table 3. Effectiveness and overcorrection of HN therapy options in TAH and SIADH patients

5. Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study
Burst et al. Am J Nephrol 2017;45:
(DOI: / )
Fig. 2. Success rate for Δ24h[Na+] 5 mEq/L but ≤12 mEq/L for distinct therapies in TAH. HS, hypertonic saline; NS, isotonic saline; FR, fluid restriction; withdrawal, immediate withdrawal of thiazide, no withdrawal; delayed or no withdrawal of thiazide. Data for tolvaptan not included in statistical testing due to low number. HS/withdrawal vs. NS/no withdrawal: p = HS/withdrawal vs. FR/withdrawal: p = HS/withdrawal vs. no therapy/withdrawal: p = HS/withdrawal vs. FR/no withdrawal: p = HS/withdrawal vs. no therapy/no withdrawal: p <  n = number of patients